SCHEMBL9865982

SCHEMBL9865982

N=C(NCCCc1c[nH]cn1)NCCSc1ccccn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
NFKB1 P19838 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
HPGD P15428 1/20 0.44
TP53 P04637 1/20 0.42
LMNA P02545 4/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
ALDH1A1 P00352 7/20 0.39
MAPT P10636 3/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
KMT2A Q03164 4/20 0.37
MEN1 O00255 2/20 0.37
PKM P14618 1/20 0.37
USP2 O75604 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9866653 0.95 NPC1 (0.39) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL9865147 0.86 MTNR1A (0.41) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL7180733 0.84 LMNA (0.37) SMN1; SMN2LMNAALDH1A1KMT2AMEN1
SCHEMBL9867497 0.81 KMT2A (0.38) NPC1RAB9ASMN1; SMN2HPGDALDH1A1
SCHEMBL9865989 0.81 EBP (0.38) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
Gapromidine SCHEMBL1818477 0.81 CYP1A2 (0.44) RAB9ASMN1; SMN2HPGDALDH1A1CYP2D6
SCHEMBL9866660 0.80 NPY1R (0.37)
SCHEMBL9866021 0.80 TEAD1 (0.43) SMN1; SMN2LMNAL3MBTL1ALDH1A1MAPT
SCHEMBL9877140 0.80 ALDH1A1 (0.40) NPC1RAB9ASMN1; SMN2HPGDLMNA
SCHEMBL9865429 0.79 EBP (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5021431-A H-1 antagonist, h-2 agonist for treating hypertension, cardiac disease or arterial occlusion HEUMANN PHARMA GMBH & CO. (DE) 1991-06-04 US disclosed
EP-0199845-A1 Imidazolylalkylguanidin derivatives, process for their preparation and pharmaceutical compositions containing them HEUMANN PHARMA GMBH & CO (DE) 1986-11-05 EP disclosed